Molecular basis of phytochemical-gut microbiota interactions

Drug Discov Today. 2023 Nov 8:103824. doi: 10.1016/j.drudis.2023.103824. Online ahead of print.ABSTRACTDysbiosis-associated molecular pathology is significantly involved in developing and perpetuating metabolic disorders, disrupting host energy regulation, and triggering inflammatory signaling cascades, insulin resistance, and metabolic dysfunction. Concurrently, numerous phytoconstituents are able to interact with the gut microbiota and produce bioactive metabolites that influence host cellular pathways, inflammation, and metabolic processes. These effects include improved insulin sensitivity, lipid metabolism regulation, and suppression of chronic inflammation, highlighting the therapeutic potential of phytoconstituents against metabolic abnormalities. Understanding this symbiotic relationship and the underlying molecular cascades offers innovative strategies for tailored interventions and promising therapeutic approaches to address the growing burden of metabolic disease.PMID:37949428 | DOI:10.1016/j.drudis.2023.103824
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Source Type: research